drome (TSS), purpura fulminans, and necrotizing pneumonia occur in individuals lacking predisposing risk factors, although the majority may have had prior upper respiratory viral infections [2] [3] [4] .
Staphylococcal superantigens are exotoxins that stimulate massive cytokine production by both T lymphocytes and macrophages [5, 6] . These cytokines include tumor necrosis factor a and b, interleukin 1b, interleukin 2, and interferon g [7] and cause many of the clinical features of TSS. Superantigens bind to and crosslink variable regions of certain b-chains of T cell receptors (Vb-TCRs) and either one or both of the aor b-chains of major histocompatibility complex (MHC) II molecules on macrophages [8, 9] .
Superantigens, such as TSS toxin-1 (TSST-1) made by CA-MRSA USA200 strains (CDC designation based on pulsed-field gel electrophoresis) and staphylococcal enterotoxins B and C (SEB and SEC, respectively) made by CA-MRSA USA400 strains [4] , are associated with TSS and other serious illnesses in humans [5, 6] . TSST-1 is associated with nearly all cases of menstrual TSS, and 50% of nonmenstrual cases. SEB and SEC are associated with most of the remaining cases of nonmenstrual TSS [10, 11] .
In the present study, we investigated the role played by these 3 superantigens produced by CA-MRSA in rabbit models of lethal pulmonary illness.
MATERIALS AND METHODS
CA-MRSA strains. USA200 strains included MNPA (menstrual TSS isolate), MN1021, and MN128. These organisms appear to be highly related, with MN1021 and MN128 coming from the same outbreak; data presented are accumulated from the use of all 3 organisms. These isolates produce elevated amounts of TSST-1 compared with USA200 Methicillin-sensitive S. aureus (MSSA) but do not produce a, b, g, or PantonValentine leukocidin (PVL) cytotoxins, and the organisms are nonpigmented [12] . The strains have mutations in the a-and g-toxin genes as determined by nucleotide sequencing and lack PVL genes as determined by polymerase chain reaction [13, 14] . USA400 strains were MW2 and c99-529, isolated from children who died of necrotizing pneumonia [4] . MW2 produces SEC, whereas CA-MRSA c99-529 produces SEB. Both of the USA400 strains also produce a-and g-toxins and PVL but not b-toxin.
Rabbits. Dutch belted rabbits (1.5-2 kg) were used in accordance with guidelines established by the University of Minnesota Institutional Animal Care and Use Committee (IACUC).
Superantigens. All reagents used for preparation of purified superantigens were maintained lipopolysaccharide-free. TSST-1 was purified to homogeneity from S. aureus clone RN4220 (pCE107); this strain does not produce other superantigens. SEB was purified from S. aureus MNHo and SEC from MW2. Superantigens were purified after growth of organisms in dialyzable beef heart media [15] . Superantigens were precipitated from culture fluids with 4 volumes of absolute ethanol, resolubilized in distilled water, and purified by thinlayer isoelectric focusing [15, 16] . Initial isoelectric focusing pH gradients were 3.5-10, followed by second gradients of pH 6-8 for TSST-1 and pH 7-9 for SEB and SEC; the isoelectric point for TSST-1 is 7.2 and for SEB and SEC is 8.3 [17, 18] . Purified superantigens were quantified using the BioRad Protein assay (BioRad), with SEB as the protein standard. Purity was confirmed by superantigen migration as single bands when subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis [19] with silver staining and reversed phase high-performance liquid chromatography [20] (also to confirm lack of contaminating lipoteichoic acid), Limulus assay to confirm lack of detectable lipopolysaccharide, and bioassays to confirm absence of detectable cytolysins, lipase, and protease [21] . Purified superantigens were also free of detectable peptidoglycan and lipopolysaccharide as demonstrated by lack of pyrogenicity with 2-h and 3-h fever peaks [22] .
Pulmonary illness model. Rabbits were administered CA-MRSA or purified superantigens through intrabronchial inoculation ( colony-forming units in 200 mL of dialyzable 9 2 ϫ 10 beef heart medium and 100-200 mg of purified superantigens in 200 mL of phosphate-buffered saline). Rabbits were anesthetized by subcutaneous injections of ketamine (25 mg/kg) and xylazine (25 mg/kg) (Phoenix Pharmaceuticals) [23] . Once under anesthesia, their necks were shaved, and small incisions were made along the tracheas. Incisions (3 mm) were made in the tracheas, and polyethylene catheters (1-mm diameter; Fisher Scientific) were inserted and threaded into the left bronchi. Bacteria or purified superantigens were administered through the catheters. Once exposed to CA-MRSA or superantigens, rabbits were monitored for up to 7 days for development of respiratory distress and lethal illness (this point is defined as death or, in agreement with the University of Minnesota IACUC and 28 years research experience, rabbit failure to exhibit both escape behavior and ability to right themselves). At this point, the animals were killed by intravenous administration of 1 mL/kg Beuthanasia D (Schering-Plough Animal Health Corp). Rabbits that did not develop respiratory distress and lethal illness were killed after 7 days.
Immunizations. Dutch belted rabbits were hyperimmunized against either purified TSST-1 or SEC before receiving intrabronchial CA-MRSA or purified superantigens. Superantigens (in phosphate-buffered saline, 0.005 mol/L NaPO 4 , pH 7.2, 0.15 mol/L NaCl) were mixed with equal volumes of incomplete Freund adjuvant (Difco Laboratories). Final concentrations of 50 mg/mL of superantigens were used for injections, with each rabbit receiving 1.0 mL, injected subcutaneously into 4 sites on the nape of the neck. Animals received initial injections, followed by booster injections every 2 weeks until antibody titers were 110,000, as determined by enzyme-linked immunosorbent assay (ELISA); antibody titers of 110,000 were considered hyperimmune (humans who do not develop menstrual TSS typically have immunoglobulin G [IgG] titers of 160). For ELISA, wells of flat-bottom 96-well plates were coated with 1.0 mg/well of purified TSST-1 or SEC [24] and washed. Rabbit serum samples were serially diluted 2-fold in the wells beginning with 1/10 dilutions; the plates were incubated for 2 h at room temperature, and then wells were washed. Horseradish peroxidase-conjugated anti-rabbit IgG (Sigma-Aldrich) were added to wells, the plates were incubated for 2 h at room temperature, and the wells were again washed. The relative levels of IgG were determined by the addition of color substrate containing o-phenylenediamine and H 2 O 2 (100 mL/well). Reactions were stopped by addition of 12.5% sulfuric acid (50 mL), and then absorbances at 490 nm wavelength were measured spectophotometrically. 
Soluble high-affinity Vb-T cell receptor (G5-8).
Some rabbits received soluble high-affinity Vb-TCR (100 mg administered intravenously daily) G5-8 in addition to CA-MRSA or superantigens. Soluble high-affinity Vb-TCR G5-8 with 48 pmol/L specificity for SEB was generated by Vb-TCR mutagenesis and selection by flow cytometry [25] . This 12,000 molecular weight molecule is highly specific for reactivity to SEB, but not SEC and TSST-1; it effectively neutralizes SEB superantigenicity and thus neutralizes lethal activity through competition with Vb-TCR.
Histology. Rabbit lung tissue samples were excised immediately upon death of animals or at the termination of experimentation (7 days), fixed in 10% formalin, and embedded in paraffin wax. Thick tissue sections (10 mm) were obtained using a microtome (Leica RM2235, Wetzlar). Sections were stained with hematoxylin (Fisher Scientific) and eosin (SigmaAldrich) (H&E) following standard protocols at the University of Minnesota Veterinary Animal Pathology Laboratory.
Statistical analyses. Data were analyzed by Fisher exact test. P values of р.05 were considered significant. The Reed and Muench method was used to calculate the median lethal dose endpoint (LD 50 ) for pulmonary exposure to purified SEC [26] .
RESULTS
CA-MRSA rabbit pulmonary model. Rabbits were exposed intrabronchially to CA-MRSA and monitored for signs of respiratory distress and lethal illness. To initiate pulmonary infections, bacteria were administered into rabbit bronchi. CA-MRSA strains tested were USA200 MNPA, MN1021 or MN128 (TSST-1 + ; these strains do not produce the cytotoxins a-toxin, b-toxin, g-toxin, and PVL), and USA400 MW2 (SEC4
, and PVL + ) [4] and USA400 c99-529 (SEB + , a-toxin + , b-toxin Ϫ , g-toxin + , and PVL + ) [4] . The animals were monitored for signs of illness for up to 7 days. Typically, rabbits exposed to CA-MRSA died 2-3 days after infection and had high fevers on days 1 and 2 after infection. Rabbits exposed to both USA200 and USA400 CA-MRSA organisms developed illness associated with respiratory distress and lethal illness, and the animals died ( Figure 1) ; only 1 of 8 animals exposed to the TSST-1 + USA200 organisms survived ( Figure 1A) , and no animals survived when challenged intrabronchially with SEC + USA400 MW2 organisms ( Figure 1B ). Excised lungs from rabbits exposed to CA-MRSA USA200 bacteria and USA400 MW2 were severely hemorrhagic ( Figure  2A -2B and 3A-3B), compared with rabbits challenged with phosphate-buffered saline ( Figure 2E-2F and 3I-3J) . Histological analysis of representative lung sections confirmed the presence of hemorrhagic tissue ( Figure 4A-4B and 5A -5B), compared with rabbits challenged with phosphate-buffered saline ( Figure 4E -4F and 5I-5J).
We attempted to construct an allelic replacement sec (gene encoding SEC) knockout to test the role of SEC in lethality in this rabbit model. Although we were successful in constructing knockouts, making isogenic strains, the strains were not iso- phenotypic. Thus, the constructed knockouts lacked production of both SEC and a-toxin (only proteins tested), despite having similar growth kinetics. Therefore, to assess the role played by TSST-1 and SEC in lethal illness in rabbits, groups of rabbits were hyperimmunized against highly purified TSST-1 or SEC (ELISA IgG titers 110,000) [15, 16] and then challenged intrabronchially with corresponding CA-MRSA isolates that produce TSST-1 or SEC. Rabbits preimmunized against TSST-1 or SEC did not develop respiratory distress or lethal illness when challenged ( and , respectively) P ! .001 P ! .005 ( Figure 1A-1B) and, other than fever, did not develop overt clinical signs.
Excised lungs removed from nonimmune animals challenged with CA-MRSA USA200 or USA400 MW2 showed hemorrhagic tissue (Figure 2A-2B and 3A-3B) . Lungs from TSST-1 or SEC hyperimmunized rabbits challenged with USA200 bacteria or USA400 MW2 did not have visible hemorrhagic lesions ( Figure 2C-2D and 3C-3D) , although the lungs appeared somewhat congested, consistent with staphylococcal infections. Lungs from rabbits treated with phosphate-buffered saline did not show hemorrhagic tissue and were not congested ( Figure  2E-2F and 3I-3J) .
Histological analysis showed hemorrhagic lung tissue in nonimmune rabbits ( Figure 4A-4B and 5A -5B) challenged with Figure 6 . Soluble high affinity variable b-chains of T cell receptors (Vb-TCR) (G5-8) protects rabbits from respiratory distress and lethal illness due to intrabronchial purified staphylococcal enterotoxin B (SEB) (100 or 200 mg). Phosphate-buffered saline or high affinity Vb-TCR (G5-8)-treated rabbits alive after intrabronchial administration of 100 (3 rabbits) or 200 mg of SEB (3 rabbits) Note that all rabbits that received Vb-TCR G5-8 were administered 200 mg of purified SEB.
CA-MRSA USA200 bacteria or MW2, normal lung tissue in TSST-1 and SEC-hyperimmunized rabbits challenged with USA200 and MW2 organisms ( Figure 4C-4D and 5C-5D ) or rabbits challenged with phosphate-buffered saline ( Figure  4E-4F and 5I-5J) .
Additional experiments investigated the ability of soluble high affinity Vb-TCR G5-8, specific for neutralization of SEB lethality in rabbits, through inhibition of superantigenicity [25] , to provide passive protection from CA-MRSA or purified SEB intrabronchial challenge. Rabbits that received high-affinity Vb-TCR G5-8 intravenously at the same time as the intrabronchial SEB + CA-MRSA c99-529 did not develop respiratory distress and lethal TSS ( Figure 1C) , whereas animals that did not receive G5-8 died.
Pulmonary exposure to purified SEB or SEC. Rabbits were administered purified SEC (0, 50, 100, or 200 mg) intrabronchially in phosphate-buffered saline. The LD 50 of SEC was 75 mg by this route. Postmortem examination of lungs from SECtreated rabbits revealed hemorrhagic tissue ( Figure 3E-3F ), compared with normal tissues from animals treated with phosphate-buffered saline ( Figure 3I-3J ).
Rabbits were also hyperimmunized against purified SEC and then administered 200 mg of SEC intrabronchially in phosphatebuffered saline. SEC hyperimmunized rabbits did not develop respiratory distress and lethal illness (data not shown) over the 7-day test period. In contrast, nonimmunized rabbits exposed to 200 mg of purified SEC showed respiratory distress and died within 24 h (data not shown). Excised lungs from nonimmunized rabbits revealed the presence of hemorrhagic lesions ( Figure 3E-3F ). Lung samples from SEC hyperimmunized rabbits did not show hemorrhagic lesions ( Figure 3G-3H) ; they resembled lungs from animals treated with phosphate-buffered saline ( Figure 3I-3J) .
Histological analysis confirmed that excised lung sections from nonimmunized rabbits administered 200 mg of SEC contained hemorrhagic lesions ( Figure 5E-5F ). Tissue from SEC hyperimmunized rabbits administered 200 mg of SEC ( Figure  5G -5H) and rabbits that received phosphate-buffered saline ( Figure 5I-5J) showed normal lung tissue. Intravenous administration of high-affinity G5-8 with intrabronchial SEB also protected rabbits from respiratory distress and lethal TSS (Figure 6 ).
DISCUSSION
We evaluated the role played by staphylococcal superantigens in serious pulmonary CA-MRSA infections and intoxications. Through TSST-1 and SEC immunization studies and use of soluble high-affinity Vb-TCR G5-8 to neutralize SEB, we showed that these 3 superantigens are critical for development of serious pulmonary illness caused by both CA-MRSA and highly purified superantigens. We used rabbits as models because these animals are more similar to humans in susceptibility to superantigens [6, [27] [28] [29] [30] [31] ; rabbits are also highly susceptible to cytotoxins [32] . Previous studies of CA-MRSA pulmonary infections used mice as the animal model [13, 33, 34] and have generated conflicting results regarding the roles played by staphylococcal exotoxins; one group suggested that PVL is critical to necrotizing pneumonia [34] , whereas other groups suggested that a-toxin and phenol-soluble modulins, but not PVL, are critical [13, 33] . However, none of these studies assessed the role played by superantigens in disease because mice are at least 10 11 more resistant to superantigens on a weight basis than are humans [35, 36] . Indeed, the presence of superantigens increases the resistance of mice to infections [37] . In contrast, young adult rabbits are only 10 2 -10 3 more resistant than humans to superantigens, and rabbits у8 months of age are as equally susceptible as humans to superantigens.
Previous hyperimmunization against TSST-1 protected rabbits from the lethality associated with intrabronchial challenge with CA-MRSA USA200. Interestingly, these CA-MRSA strains do not produce a, b, g, or PVL cytotoxins, yet they cause fatal pulmonary illness. The studies suggest that cytotoxins are not required for the fatal outcomes. Our hyperimmunization of rabbits against PVL followed by challenge with USA400 MW2 (SEC + , a-toxin
, and PVL + ) resulted in lethal pulmonary illnesses, suggesting that PVL is not critical for lethality (unpublished data). It appears that these redundantly expressed cytotoxins, including a-toxin, b-toxin, g-toxin, and PVL, when produced, contribute significantly to serious lung diseases, either through direct toxicity or induction of inflammation, but are not required for lethality in rabbits.
Presently, MRSA and their MSSA counterparts are highly significant causes of infectious disease deaths in the United States, including fatal pulmonary infections [3] . Our data suggest that superantigens are important contributors to those fatal infections. The initial report of CA-MRSA USA400 strains associated with deaths of 4 young children in the Upper Midwest due to necrotizing pneumonia demonstrated that 2 isolates produced SEB and the other 2 produced SEC, including MW2 and c99-529 [4] . Nonimmunized rabbits used in our studies that received intrabronchial MW2 and c99-529 developed illness that resembled necrotizing pneumonia, including by histologic examination of lung tissue. A subsequent larger study of CA-MRSA USA400 strains indicated that the vast majority produce either SEB or SEC [38] . It is also our experience that some regions of the United States are experiencing emergences of CA-MRSA USA200 S. aureus that produce TSST-1. As shown in the present studies, TSST-1 is critical in fatal pulmonary illness associated with these strains.
Of great significance, our studies show that administration of soluble high-affinity Vb-TCR G5-8 or prior hyperimmunization to raise neutralizing antibodies against superantigens dramatically increases rabbit survival. There are anecdotal studies of patients with severe S. aureus pulmonary infections being treated successfully with intravenous immunoglobulin (IVIG) [39, 40] . IVIG is highly capable of neutralizing superantigens [41] . Additionally, a study has shown that IVIG reduces the case: fatality rate of streptococcal TSS in humans. However, IVIG is costly, requires large amounts of immunoglobulin to be administered, and has side effects. Our previous studies have shown that the soluble high-affinity Vb-TCR G5-8 requires 2200 times less than IVIG for comparable ability to neutralize SEB in rabbits. G5-8 is easy to prepare from bacterial clones and requires only equimolar amounts to neutralize SEB, such small amounts for SEB neutralization that it may be possible to nebulize into the lungs, as well as administered intravenously.
